摘要
胰高血糖素样肽-1类似物艾塞那肽是一种全新作用机制的降糖药物,具有降低血糖而不引起低血糖且有降低体质量的作用,还具有心血管保护作用和抑制乳腺癌细胞增长作用。本文对艾塞那肽近期的国内外文献进行分析,从其临床应用研究、新剂型研究、安全性等方面阐述其研究进展。
Glucagon-like peptide-1 （GLP-1） analogue exenatide is a new type of antidiabetic drug with a new action mechanism. It can lower blood sugar without causing hypoglycemia and reduce body weight. It has cardiovascular protective effects and can inhibit breast cancer cell growth. In this paper the recent literatures about the exenatide both at home and abroad were reviewed and analyzed and the research progress on the clinical application, the new form preparation and safety, etc. was introduced.
出处
《中国执业药师》
CAS
2013年第7期38-39,53,共3页
China Licensed Pharmacist
